Unknown

Dataset Information

0

Cross-species comparison of CAR-mediated procarcinogenic key events in a 3D liver microtissue model.


ABSTRACT: Characterisation of the mode of action (MOA) of constitutive androstane receptor (CAR)-mediated rodent liver tumours involves measurement 5 key events including activation of the CAR receptor, altered gene expression, hepatocellular proliferation, clonal expansion and increased hepatocellular adenomas/carcinomas. To test whether or not liver 3D microtissues (LiMTs) recapitulate CAR- mediated procarcinogenic key events in response to the prototypical CAR activator phenobarbital (PB) we performed hepatocyte proliferation (LI%) analysis in rat and human LiMTs using a microTMA technology in conjunction with integrated transcriptomics (microarray) and proteomics analysis. The rationale for this approach was that LiMTs containing parenchymal and non-parenchymal cells (NPCs) are more physiologically representative of liver and thus would generate data more relevant to the in vivo situation. Rat and human LiMTs were treated with PB over a range of concentrations (500?uM - 2000?uM) and times (24?h - 96?h) in a dose-response/time-course analysis. There was a dose-dependent induction of LI% in rat LiMTs, however there was little or no effect of PB on LI% in human LiMTs. ATP levels in the rat and human LiMTs were similar to control in all of the PB treatments. There was also a dose- and time-dependent PB-mediated RNA induction of CAR regulated genes CYP2B6/Cyp2b2, CYP3A7/Cyp3a9 and UGT1A6/Ugt1a6 in human and rat LiMTs, respectively. These CAR regulated genes were also upregulated at the protein level. Ingenuity pathways analysis (IPA) indicated that there was a significant (Z score >2.0;-log p value >) activation of CAR by PB in both human and rat LiMTs. These results indicate that human and rat LiMTs showed the expected responses at the level of PB-induced hepatocyte proliferation and enzyme induction with rat LiMTs showing significant dose-dependent effects while human LiMTs showed no proliferation response but did show dose-dependent enzyme induction at the RNA and protein levels. In conclusion LiMTs serve as a model to provide mechanistic data for 3 of the 5 key events considered necessary to establish a CAR-mediated MOA for liver tumourigenesis and thus can potentially reduce the use of animals when compiling mechanistic data packages.

SUBMITTER: Plummer S 

PROVIDER: S-EPMC6816142 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cross-species comparison of CAR-mediated procarcinogenic key events in a 3D liver microtissue model.

Plummer Simon S   Beaumont Bobby B   Wallace Stephanie S   Ball Graeme G   Wright Jayne J   McInnes Liz L   Currie Richard R   Peffer Rich R   Cowie David D  

Toxicology reports 20190924


Characterisation of the mode of action (MOA) of constitutive androstane receptor (CAR)-mediated rodent liver tumours involves measurement 5 key events including activation of the CAR receptor, altered gene expression, hepatocellular proliferation, clonal expansion and increased hepatocellular adenomas/carcinomas. To test whether or not liver 3D microtissues (LiMTs) recapitulate CAR- mediated procarcinogenic key events in response to the prototypical CAR activator phenobarbital (PB) we performed  ...[more]

Similar Datasets

2006-05-30 | GSE3584 | GEO
| S-EPMC8222189 | biostudies-literature
2005-01-25 | GSE2009 | GEO
2010-06-10 | E-GEOD-2009 | biostudies-arrayexpress
| S-EPMC4124885 | biostudies-literature
| S-EPMC10362508 | biostudies-literature
| PRJNA91829 | ENA
2014-02-01 | E-GEOD-54597 | biostudies-arrayexpress
2024-09-27 | PXD056101 | Pride
| S-EPMC3203927 | biostudies-literature